PHIO
Phio Pharmaceuticals·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
PHIO Filings
Filing Date
Form Description
Form Type
2025-12-04
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-04 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-04
Form EFFECT - Notice of Effectiveness
2025-12-04 ·
Form EFFECT - Notice of Effectiveness
2025-11-25
Form 8-K - Current report
Key Events
2025-11-25 · Key Events
Form 8-K - Current report
2025-11-24
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-24 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-24
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-24 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-20
Form S-3 - Registration statement under Securities Act of 1933
2025-11-20 ·
Form S-3 - Registration statement under Securities Act of 1933
2025-11-19
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-19 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-13
Form 8-K - Current report
Key Events
2025-11-13 · Key Events
Form 8-K - Current report
2025-11-13
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-13 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-12
Form D - Notice of Exempt Offering of Securities
2025-11-12 ·
Form D - Notice of Exempt Offering of Securities
